Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001237334-26-000002

Director sold 1,000 shares at $510.00 ($510,000)

  • Director acquired 1,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
CAUSEY CHRISTOPHER Director 2026-01-06 Option exercise 10b5-1 +1,000 $119.76 $119,760 5,190 D: show line 1 in the form
CAUSEY CHRISTOPHER Director 2026-01-06 Sale 10b5-1 −1,000 $510.00 $510,000 4,190 D: show line 2 in the form
Open-market sales · 1,000 sh · avg $510.00 · $510,000

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
CAUSEY CHRISTOPHER Director 2026-01-06 Option exercise · Stock Option 10b5-1 −1,000 7,320 D: show line 3 in the form
Loading xslF345X05/primarydocument.xml…